MAIA

Handel nachbörslich: 1.88

MAIA Biotechnology Inc (MAIA)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

MAIA Biotechnology Inc Stock (MAIA) Company Profile

MAIA Biotechnology Inc

Healthcare (1173)

Biotechnology (678)

312 416 8592

444 West Lake Street, Suite 1700, Chicago

Nächster Verdiensttermin

Neueste SEC-Einreichungen

MAIA's Discussions on Twitter

Vergleichen Sie MAIA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MAIA MAIA Biotechnology Inc	1.88	49.18M	0	-25.94M	-15.79M	-1.38
VRTX Vertex Pharmaceuticals Inc	461.68	118.90B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	672.98	73.95B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	655.13	39.81B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	271.31	34.99B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	123.77	29.67B	3.30B	-501.07M	1.03B	-2.1146

MAIA Biotechnology Inc Aktie (MAIA) Neueste Nachrichten

Finanzdaten der MAIA Biotechnology Inc-Aktie (MAIA)

MAIA Biotechnology Inc (MAIA)

MAIA Biotechnology Inc Stock (MAIA) Company Profile

Vergleichen Sie MAIA mit anderen Aktien

MAIA Biotechnology Inc Aktie (MAIA) Neueste Nachrichten

MAIA Biotechnology, BeiGene announce clinical supply agreement - The Cancer Letter

Geode Capital Management LLC Grows Position in MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) - Defense World

MAIA Biotech to Present THIO Cancer Treatment Pipeline at Biotech Showcase 2025 - StockTitan

MAIA Biotechnology Shares Rise After Supply Agreement With BeiGene - MarketWatch

MAIA Biotechnology Announces Clinical Supply Agreement with BeiGene for Upcoming Phase 2 Trials in Three Cancer Indications - BioSpace

MAIA Biotech partners with BeiGene for cancer trials - Investing.com

MAIA Biotechnology Directors Show Strong Confidence with $573K Personal Investment in Private Placement - StockTitan

MAIA Biotechnology Announces Director Participation in Recent Private Placement Closings - Business Wire

Big Moves at MAIA Biotechnology! Insider Buying and Market Insights - Clinique Bio

MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas - Business Wire

Investing Insights: MAIA Biotechnology’s Promising Moves - Clinique Bio

Stan Smith Acquires 25,000 Shares of MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Stock - MarketBeat

Maia Biotechnology director Stan Smith acquires $46,800 in stock - Investing.com India

Maia Biotechnology director Stan Smith acquires $46,800 in stock By Investing.com - Investing.com South Africa

Maia Biotechnology director Ramiro Guerrero buys $99,998 in stock - Investing.com

Maia Biotechnology director Ramiro Guerrero buys $99,998 in stock By Investing.com - Investing.com UK

MAIA Biotechnology, Inc. announced that it expects to receive $0.949785 million in funding - Marketscreener.com

MAIA Biotechnology announces $950,000 private placement - MSN

MAIA Biotechnology Secures $950K Private Placement to Advance THIO Clinical Trials - StockTitan

MAIA Biotech expands phase 2 trial for lung cancer treatment By Investing.com - Investing.com South Africa

MAIA Biotechnology Announces Expansion of Clinical Supply Agreement with Regeneron for Phase 2 Trial in Non-Small Cell Lung Cancer - XM

MAIA Biotech expands phase 2 trial for lung cancer treatment - Investing.com

MAIA Biotech Expands Cancer Trial with Regeneron, Reports Promising NSCLC Results - StockTitan

Diamond Equity Forecasts MAIA Biotechnology Q1 Earnings - Defense World

Analysts Set Expectations for MAIA Biotechnology Q1 Earnings - MarketBeat

MAIA Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

THIO Combo Shows Enduring Activity in Advanced Non–Small Cell Lung Cancer - Cancer Network

MAIA Biotechnology Inc (MAIA): A New Perspective - Stocks Register

MAIA Biotechnology Reveals Promising Phase 2 Trial Results - TipRanks

MAIAMAIA Biotechnology, Inc. Latest Stock News & Market Updates - StockTitan

MAIA Biotechnology Announces Participation by Director Stan Smith, Ph.D. in Recent Private Placement - BioSpace

MAIA Director Backs Cancer Drug Developer with $225,900 Stock Purchase, Shows Insider Confidence - StockTitan

MAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting - Yahoo Finance

Maia Biotechnology director Stan Smith buys shares worth $250,999 - Investing.com

Maia Biotechnology director Stan Smith buys shares worth $250,999 By Investing.com - Investing.com Canada

Insider Buying: MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Director Acquires 22,133 Shares of Stock - MarketBeat

Director Cristian Luput Acquires 22,133 Shares of MAIA Biotechno - GuruFocus.com

Director Ramiro Guerrero Acquires 88,534 Shares of MAIA Biotechn - GuruFocus.com

Maia Biotechnology director Steven Chaouki buys $55,553 in shares By Investing.com - Investing.com Australia

Maia Biotechnology director Steven Chaouki buys $55,553 in shares - Investing.com

Maia Biotechnology director Luput acquires shares worth $55,553 By Investing.com - Investing.com Nigeria

Maia Biotechnology director Luput acquires shares worth $55,553 - Investing.com

Cosmo Metals Secures $500,000 for Strategic Expansion - MSN

Antipa Minerals Expands Share Offering on ASX - MSN

WAM Alternative Assets Expands ASX Securities Offering - MSN

Argent BioPharma Issues New Shares Amidst Strategic Growth - MSN

MAIA Biotechnology Announces $2.44 Million Private Placement - Business Wire

MAIA Biotechnology (NYSEAMERICAN:MAIA) Stock Price Down 3.4%Here's What Happened - MarketBeat

MAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Down 3.4% – Time to Sell? - Defense World

Alterity Therapeutics Prepares for 2024 Annual General Meeting - MSN

Li Bang International announces pricing of initial public offering - MSN

Finanzdaten der MAIA Biotechnology Inc-Aktie (MAIA)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie MAIA